Immunic investor relations
Witryna8 lut 2024 · Mersana Fourth Quarter 2024 Earnings Call. February 28, 2024 at 8:00 AM EST. Listen to webcast. Witryna10 lis 2024 · Members of Immunic's management and investor relations teams will attend this virtual conference. To schedule a meeting, please contact an Evercore representative. ... Head of Investor Relations ...
Immunic investor relations
Did you know?
Witryna14 lip 2024 · NEW YORK, July 14, 2024 /PRNewswire/ -- Immunic, Inc. (the "Company") (Nasdaq: IMUX ), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies ... Witryna1 kwi 2024 · SAN DIEGO , March 14, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company will present a quantitative systems pharmacology (QSP) model for predicting the effects of the investigational enzyme replacement therapy pegtibatinase, in classical …
Witryna31 gru 2024 · Results of Operations. The Company reported a net loss of $41.5 million for the year ended December 31, 2024, which compared with a net loss of $52.1 million for the prior year. This resulted in a net loss of $0.98 per share for the year ended December 31, 2024, as compared to a net loss of $1.31 per share for 2024, on both a … Witryna5 sty 2024 · Investor Relations. Investor/Media Home; Press Releases; Events & Presentations; Analyst Coverage; Stock Information; SEC Filings; Corporate Governance; Investors/Media FAQs - Landos - Investor Tools. Print Page; RSS Feeds; Email Alerts; Landos Biopharma, Inc. PO Box 11239 Blacksburg, VA 24062. …
Witryna26 lut 2024 · /PRNewswire/ -- Immunic, Inc. (Nasdaq: ... Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … Witryna1 wrz 2024 · Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune ...
Witryna2 lut 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx Communications Group Paula …
Witryna14 mar 2024 · Seed-Investment des HTGF: Münchner Startup oculai schließt 2,5 Mio. € Seed-Runde zur KI-gestützten Prozesserfassung auf Baustellen ab ... Parcellab, Cobrainer, Quantum Systems, Casavi, Riskmethods, Tubulis, Catalym, Immunic, Sirion und viele weitere. ... Stefanie Grüter, Partner Communications & Relations T.: +49 … sharkgulf technology shanghai co. ltdWitryna12 kwi 2024 · Immunic, Inc. Jessica Breu Manager IR and Communications +49 89 250 0794 69 [email protected] Or Rx Communications Group Melody Carey +1-917-322-2571 [email protected] popular family room colorsWitryna11 kwi 2024 · The trading price of Immunic Inc. (NASDAQ:IMUX) closed lower on Monday, April 10, closing at $1.33, -4.32% lower than its previous close. In examining … popular family vacations 2019Witryna13 kwi 2024 · Overview. Rocket Companies (NYSE: RKT) is a Detroit-based holding company consisting of personal finance and consumer service brands. Founded by Dan Gilbert, tech-driven Rocket Companies provides industry-leading real estate, mortgage and financial services, empowering consumers through entities including Rocket … popular family hotels londonWitryna6 lis 2024 · Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q3 2024 Earnings Conference Call November 3, 2024 8:00 AM ETCompany ParticipantsJessica Breu - Head, IR and CommunicationsDaniel Vitt - CEO and... shark gummy peach clearance 3 mgWitryna22 lut 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group Paula Schwartz +1 917 633 7790 [email protected] shark guy outdoorsWitrynaInvestor Relations. Athenex is a global oncology focused biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, aiming to develop safer and more efficacious cancer medication. Founded in 2003 and based in Buffalo, New York, our mission is to improve the lives … popular famous people 2022